Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate

Assessment of Tumor Resistance and Stem Cells in Prostate Cancer

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00991315

Enrollment

126

Registered

2009-10-08

Start date

2008-12-12

Completion date

2017-04-10

Last updated

2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

prostate cancer

Brief summary

The primary objective of this study is to collect material for study's to assess mechanisms of tumor progression, mechanisms of resistance, isolation of stem cells and biologic markers in tissue, serum and peripheral blood mononuclear cells.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

DISEASE CHARACTERISTICS: * Undergoing routine prostatectomy or transurethral resection of the prostate (TURP) PATIENT CHARACTERISTICS: 5.1.1 Patient is undergoing routine prostatectomy or TURP. 5.1.2 Patient is ≥ 18 years old. 5.1.3 Patient must give informed consent. PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Design outcomes

Primary

Measure	Time frame
Collection and freezing of tumor samples	5 years

Countries

United States

Outcome results